07 October, 2025 Soft mist inhaler nebulisation by Rayleigh-breakup largely preserves functional integrity of liposomal mRNA in respirable aerosols Read More
15 August, 2025 Evaluation of Rayleigh jet atomiser for intranasal delivery of lipid nanoparticle – siRNA formulations: stability, deposition, and device performance Read More
18 June, 2025 Rayleigh-based soft mist inhalers preserve mRNA-LNP integrity for pulmonary delivery Read More
08 February, 2025 Targeted nasal delivery of LNP-mRNAs aerosolised by Rayleigh breakup technology Read More
19 December, 2023 Improved olfactory deposition of theophylline using a nanotech soft mist nozzle chip Read More
05 July, 2023 Low energy nebulisation preserves integrity of SARS-CoV-2 mRNA vaccines for respiratory delivery Read More
04 November, 2022 Pulmonary delivery of favipiravir in rats reaches high local concentrations without causing oxidative lung injury or systemic side effects Read More
21 August, 2022 Pulmonary delivery of favipiravir inhalation solution for COVID-19 treatment: in vitro characterisation, stability, in vitro cytotoxicity, and antiviral activity using real time cell analysis Read More
